We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 0.75% | 1,351.50 | 1,351.00 | 1,352.00 | 1,353.00 | 1,341.00 | 1,341.00 | 1,015,103 | 10:08:39 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.33 | 55.61B |
Date | Subject | Author | Discuss |
---|---|---|---|
06/5/2021 07:58 | The Times business report of yesterday. "Whispers that AZ and GSK had both been sniffing around Aurinia a biotech company on Naz value C$2B | whatsup32 | |
06/5/2021 07:40 | Never going to happen | watfordhornet | |
06/5/2021 07:14 | GSK will be free to copy patent and sell for profit | whatsup32 | |
06/5/2021 07:10 | Spud - "Well they certainly haven’t in the long term ffs!" Absolutely agree, but the choice for GSK would have been to ditch the divi a few years ago and spend on building up, including buying assets, on the pharma side, or do what they're doing now. So they've determined to keep the divi whilst working to create cash for pharma with the split. If they'd ditched the divi, it would still have taken time to get results, and then there'd have been a few disgruntled investors on these pages, by crikey, lol. Truth is guys, if investors don't like it - invest elsewhere. I'm staying. I can see the potential. | poikka | |
06/5/2021 07:01 | Suspending vaccine patents sounds great, but makes no sense. Licensing is a far better route to take. If India can send spaceships to the moon or wherever, then they should have been able to afford to deal with the pandemic. They failed and now they want to shift the blame onto others for not sharing the patents. Capitalism is all about incentives, and why bother when your efforts are going to be wasted. The Covax scheme, to which the UK has contributed greatly, should be the way to go for genuinely poor nations. The rest need to get their houses in order - starting with the EU, lol. Then there's the matter of transferring technology and manpower, within a reasonable time-frame, to countries where oversight is abysmal and the likelihood of getting safe and secure production, questionable. Not to mention fair distribution. | poikka | |
06/5/2021 06:39 | AZN does it for free anyway so does not really affect UK. | netcurtains | |
06/5/2021 06:38 | Seen that Biden just screwed the covid vaccine makers. | montyhedge | |
06/5/2021 06:27 | US moves to suspended covid vaccine patents. Sorry can't provide link on phone . FT. Front page main article. Shares in maderna, novatex..down between 3 to 6% | whatsup32 | |
05/5/2021 17:46 | Of course, if you just count the last fifteen years as short term then the management has succeeded in not boosting the share price, obviously over this not very discerning period. I wonder over what period long term shareholder interests are judged. Gosh, they really know how to reward the owners of the business! ! This really gives me a warm feeling-- I think not! | gregmorg | |
05/5/2021 17:38 | Well they certainly haven't in the long term ffs!spud | spud | |
05/5/2021 17:35 | Why on earth should they try to boost the share price in the short term!! No company should be looking for a short term boost to the share price FFS, give me strength. | poikka | |
05/5/2021 17:32 | From GSK GlaxoSmithKline plc (GSK) today announced the European Commission has approved the expanded use of intravenous and subcutaneous BENLYSTA (belimumab) in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis (LN) in Europe, in addition to systemic lupus erythematosus (SLE). The EU marketing authorisation follows the recent approval for the similar expanded LN indication in the U.S. | poikka | |
05/5/2021 15:25 | Spud - a veritable triumph! ). | essentialinvestor | |
05/5/2021 15:20 | A vertical drop but only for GSK while the Ftse goes shooting up 120 points,total sham . | abdullla | |
05/5/2021 15:01 | Tulloch from av. Had the same attitude to shareholders, he ended to going, hopefully the same will happen with EW. | igoe104 | |
05/5/2021 14:58 | Shocking and irresponsible statement if that’s what the chair actually said. | dbadvn | |
05/5/2021 14:54 | EW shouldn't be even be in the job in the first place, its got who you know written all over it. No wonder the S/P in hitting 25 year lows. How the hell did she get a massive payrise, what she done to deserve it ? | igoe104 | |
05/5/2021 14:48 | “It is not our intention to boost the share price in the short term." So mission Statement = Accomplished! Oh dear.... spud | spud | |
05/5/2021 14:42 | Is there a recording of the AGM anywhere? | watfordhornet | |
05/5/2021 14:42 | Did he really say that? Surely not | watfordhornet | |
05/5/2021 13:59 | Emma’s presentation was polished. | spyder |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions